5am Opportunities I (gp), Llc - Net Worth and Insider Trading
5am Opportunities I (gp), Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, 5am Opportunities I (gp), Llc owns 12 companies in total, including Aprea Therapeutics Inc (APRE) , Akouos Inc (AKUS) , and scPharmaceuticals Inc (SCPH) among others .
Click here to see the complete history of 5am Opportunities I (gp), Llc’s form 4 insider trades.
Insider Ownership Summary of 5am Opportunities I (gp), Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APRE | Aprea Therapeutics Inc | 2019-10-07 | 10 percent owner |
AKUS | Akouos Inc | 2020-06-25 | 10 percent owner |
SCPH | scPharmaceuticals Inc | 2020-05-26 | other: See Remarks |
2019-10-29 | 10 percent owner | ||
2021-04-27 | 10 percent owner | ||
2020-11-11 | 10 percent owner & Former 10% holder | ||
2021-10-28 | 10 percent owner | ||
2021-07-29 | 10 percent owner | ||
2021-02-04 | 10 percent owner | ||
2021-12-03 | 10 percent owner | ||
2022-01-06 | 10 percent owner | ||
2023-02-23 | 10 percent owner |
5am Opportunities I (gp), Llc Trading Performance
5am Opportunities I (gp), Llc Ownership Network
Ownership Network List of 5am Opportunities I (gp), Llc
Ownership Network Relation of 5am Opportunities I (gp), Llc
5am Opportunities I (gp), Llc Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
5am Opportunities I (gp), Llc is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, 5am Opportunities I (gp), Llc made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
5am Opportunities I (gp), Llc Mailing Address
Above is the net worth, insider trading, and ownership report for 5am Opportunities I (gp), Llc. You might contact 5am Opportunities I (gp), Llc via mailing address: 501 2nd Street, Suite 350, San Francisco Ca 94107.